CLASS I Device recall · Reported 20 Aug 2014 · FDA Enforcement Report

CSI Cardiovascular Systems, Inc. recalled

Cardiovascular Systems is recalling CSI Cardiovascular Systems, Inc., Diamondback 360 Peripheral Orbital Atherectomy System, distributed nationwide in the US. The recall was initiated on 23 May 2014 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codes100573, 100575, 100674, 100676, 100678, 100680.
Quantity recalled48

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2155-2014
FDA event ID
68806
Recalling firm
Cardiovascular Systems, Saint Paul, MN
Classification
Class I
Status
Terminated
Recall initiated
23 May 2014
FDA classified
14 Aug 2014
Reported
20 Aug 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter

Timeline

23 May 2014Recall initiated by company
14 Aug 2014Classified by FDA+83 days
20 Aug 2014Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CSI has initiated a recall on the Diamondback 360 Peripheral Orbital Atherectomy Device because it may contain a saline sheath that may experience cracking, fracture, and release particulate during use.

Product as listed by the FDA

CSI Cardiovascular Systems, Inc., Diamondback 360 Peripheral Orbital Atherectomy System, Model Number DBP-125MICRO145, Part Number 7-10003. The Diamondback 360 Peripheral Orbital Atherectomy System is a percutaneous orbital atherectomy system indicated for use as therapy in patients with occlusive atherosclerotic disease in peripheral arteries and who are acceptable candidates for percutaneous transluminal atherectomy. The OAS supports removal of stenotic material from artificial arteriovenous dialysis fistulae (AV shunt). The system is a percutaneous orbital atherectomy system indicated as a therapy in patients with occluded hemodialysis grafts who are acceptable candidates for percutaneous transluminal angioplasty.

Where it was distributed

Nationwide Distribution including AZ, AR, CA, CT, FL, IL, IA, MD, MI, NY, NC, PA, TN,and TX.

Nationwide ArkansasArizonaCaliforniaConnecticutFloridaIowaIllinoisMarylandMichiganNorth CarolinaNew YorkPennsylvaniaTennesseeTexas

Questions about this recall

Why was it recalled?

CSI has initiated a recall on the Diamondback 360 Peripheral Orbital Atherectomy Device because it may contain a saline sheath that may experience cracking, fracture, and release particulate during use.

Which lots are affected?

100573, 100575, 100674, 100676, 100678, 100680.

Where was it sold?

Nationwide Distribution including AZ, AR, CA, CT, FL, IL, IA, MD, MI, NY, NC, PA, TN,and TX.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Cardiovascular Systems

All 15

Other Heart & Vascular Devices recalls

All 6,217